Physician profile
Erik A Eways
NPI 1043266919
$953.95
in general payments reported to CMS, 2019-2025
13 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $219 · 2021: $26.08 · 2022: $227 · 2023: $73.05 · 2024: $23.30 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $431.69 | 2019-2020 | |
| Biotronik INC. | $136.92 | 2022 | |
| Abbott Laboratories | $81.26 | 2021-2025 | Diamondback Coronary, Xience Skypoint |
| Amgen INC. | $66.71 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.11 | 2022-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $50.00 | 2025 | Verquvo |
| Scpharmaceuticals INC. | $34.61 | 2023-2025 | |
| Medtronic, INC. | $23.30 | 2024 | Onyx Frontier |
| Kiniksa Pharmaceuticals, LTD. | $16.37 | 2023 | Arcalyst |
| Amarin Pharma, INC. | $15.08 | 2023 | |
| Abiomed | $14.26 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.81 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Eways listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.